ZURZUVAE, the first and only oral, once-daily, 14-day treatment course, has shown to provide rapid improvements in depressive symptoms at Day 15 and as early as Day 3 for women with PPD
Patient support program, ZURZUVAE For You, and financial assistance available to eligible women with PPD prescribed ZURZUVAE
Patients will receive prescriptions directly at home via specialty pharmacy distribution model
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.